Verastem Oncology
VSTM
#6555
Rank
A$1.20 B
Marketcap
A$9.56
Share price
-7.73%
Change (1 day)
-33.46%
Change (1 year)

Market capitalization of Verastem Oncology (VSTM)

Market cap: A$1.20 Billion

As of November 2026 Verastem Oncology has a market cap of A$1.20 Billion. This makes Verastem Oncology the world's 6555th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Verastem Oncology from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026A$1.20 B32.96%
2025A$0.90 B241.42%
2024A$0.26 B-12.07%
2023A$0.30 B142.95%
2022A$0.12 B-75.88%
2021A$0.51 B9.54%
2020A$0.47 B206.7%
2019A$0.15 B-56.44%
2018A$0.35 B77.13%
2017A$0.19 B245.75%
2016A$57.47 M-39.06%
2015A$94.31 M-69.02%
2014A$0.30 B-5.95%
2013A$0.32 B87.93%
2012A$0.17 B

End of Day market cap according to different sources

On Nov 20th, 2026 the market cap of Verastem Oncology was reported to be:

A$1.20 Billion
by Nasdaq info icon info icon
A$1.20 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
A$235.95 B 19,478.93%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$45.03 B 3,637.24%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$144.63 B 11,901.58%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
A$6.13 M-99.49%๐Ÿ‡บ๐Ÿ‡ธ USA